32
Participants
Start Date
September 2, 2019
Primary Completion Date
May 1, 2020
Study Completion Date
November 30, 2022
Atazanavir 300mg/ Ritonavir 100 mg once daily
There is no intervention in this study - participants will all be receiving atazanavir (usually boosted with ritonavir) as part of their routine clinical care
Atazanavir 250 mg / ritonavir 80 mg
There is no intervention in this study - participants will all be receiving atazanavir (usually boosted with ritonavir) as part of their routine clinical care. This dose of 250/ 80 is for participants weighing between 15 and 25 Kg
Desmond Tutu HIV Foundation, Cape Town
University of Cape Town, Cape Town
Infectious Diseases Institute, Kampala
Joint Clinical Research Centre, Kampala
Collaborators (1)
Makerere University
OTHER
Joint Clinical Research Centre- Kampala
UNKNOWN
Desmond Tutu HIV Foundation
OTHER
University of Cape Town
OTHER
European and Developing Countries Clinical Trials Partnership (EDCTP) - funder
UNKNOWN
University of Liverpool
OTHER